Keyphrases
Vismodegib
79%
Advanced Basal Cell Carcinoma
71%
Clinical Trials
59%
Basal Cell Carcinoma
59%
Adverse Events
44%
Hedgehog Inhibitor
43%
Phase II Trial
31%
Rosaceae
31%
Nevoid Basal Cell Carcinoma Syndrome
29%
Dermatologic Surgery
29%
Cutaneous Malignancy
27%
Core Domain Set
27%
Plasminogen Activator
27%
Papulopustular Rosacea
27%
Clinical Practice
27%
Psoriatic Arthritis
27%
Consensus Statement
27%
Psoriasis
27%
Azelaic Acid
27%
Metastatic Basal Cell Carcinoma
26%
Treatment Options
24%
Expanded Access
22%
Hedgehog Signaling
21%
Atopic Dermatitis
20%
Skin Cancer
19%
Tolerability
17%
Psoriasis Treatment
16%
Adverse Event Rates
16%
Melanoma
16%
Pooled Analysis
16%
Skin Diseases
16%
Clinical Outcomes
15%
Vehicle Control
15%
Randomized Double-blind
15%
Advanced or Metastatic
14%
Therapy Efficacy
14%
Hematological Cancer
13%
Membrane Association
13%
Antipruritic
13%
Ichthyosis Linearis Circumflexa
13%
Genetic Pathways
13%
Pathway Interaction
13%
Treatment Recommendations
13%
Uniform Protocol
13%
Acne Treatment
13%
Alopecia Areata
13%
Impact on Care
13%
Nalmefene
13%
Opiods
13%
Moderate-to-severe Psoriasis
13%
Medicine and Dentistry
Clinical Trial
60%
Rhinophyma
54%
Basal-Cell Carcinoma
43%
Adverse Event
41%
Cancer
29%
Acneiform Eruption
27%
Papulopustular
27%
Azelaic Acid
27%
Skin Surgery
27%
Psoriasis
26%
Dermatology
19%
Hedgehog Signaling
19%
Quality of Life
16%
Social Media
16%
Skin Cancer
15%
Psoriasis Vulgaris
15%
Signal Transduction
14%
Targeted Therapy
13%
Biopsy
13%
Scar Formation
13%
Skin Biopsy
13%
Patient-Reported Outcome
13%
Chinese (Language)
13%
Nodular Melanoma
13%
Emerging Treatment
13%
Ixekizumab
13%
Alopecia Areata
13%
Dermatosis
13%
Prospective Study
13%
Gorlin Syndrome
13%
Cardiovascular System
13%
Demography
13%
Psoriatic Arthritis
13%
Patient Care
13%
Disease
12%
Nevus Sebaceous
11%
Placebo
11%
Outcome Assessment
10%
Dermatological Agent
10%
Malignant Neoplasm
9%
Clinician
8%
Treatment Response
7%
Vismodegib
7%
Erythema
6%
Itraconazole
6%
Infection
5%
Sunscreen
5%
Sun Protection
5%
Meta-Analysis
5%
Quality of Life Assessment
5%
Pharmacology, Toxicology and Pharmaceutical Science
Basal Cell Carcinoma
100%
Vismodegib
75%
Hedgehog
51%
Clinical Trial
34%
Psoriasis
30%
Rosacea
27%
Melanoma
27%
Azelaic Acid
27%
Psoriatic Arthritis
27%
Plasminogen Activator
27%
Nevus
25%
Malignant Neoplasm
24%
Adverse Event
19%
Tolerability
17%
Atopic Dermatitis
16%
Acne
13%
Basal Cell Nevus Syndrome
13%
Skin Manifestation
13%
Pruritus
13%
Mouse
13%
Antimitotic Agent
13%
Antipruritic Agent
13%
Scar Formation
13%
Alopecia Areata
13%
Nalmefene
13%
Cyclophosphamide
13%
Congenital Disorder
13%
Skin Disease
13%
Ichthyosis
13%
Prospective Study
13%
Colchicine
10%
Disease
9%
Genetic Disorder
9%
Arthropathy
9%
Vinblastine
6%
Chemotherapy
6%
Erythema
6%
Nocodazole
6%
Cytochalasin B
6%
Itraconazole
6%
Skin Cancer
5%
